header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

CERAMIC/POLY VS METAL/METAL IN THA: A SIX YEAR’S.FOLLOW UP. CLINICAL AND X-RAY RESULTS.



Abstract

Our experience with metal/metal desings in France date from 1994. The goal of this study is to communicate our primary and comparative clinical results of 90 implants followed a minimum of 6 years

Material and method: We have reviewed the first 94 patients from our first year using metal/metal.90 case files were complete and we compare thes patients (group 1) to a control group of 90 patients receiving ceramic/poly couple, operated in the same time period (group two) with the same hybrid TH system. Average follow up: Five years and eight months.

Results and discussion: 4 of the 94 were unavailable for follow up at six years. None of these patients experienced clinical problems relared to the metal/metal. The clinical results (Merle and Harris score) are all good or excellent and there is no difference between the 2 groups. The x-ray results: For acetabular cup the two groups are identical and for femoral component (Barrack evaluation) all two groups have the same quality of cementation and maintain the cement mantle integrity achieved post-op. We decided therefore to examine specially the RLL changes in zone seven (comparison 3 month x-ray/latest follow-up x-ray); significant differences between the two groups were found in this study: The lower incidence of zone seven radiolucent changes in group one indicates a better clinical tolerance in the metal/metal configuration (p=0.0256). Considering the results reported here and the advanced studies, we can confirm that metal/metal systems are not the unique answer to PE-wear and THA longevity, but it is one solution that is available today and seems trustable.

The abstracts were prepared by Nico Verdonschot. Correspondence should be addressed to him at Orthopaedic Research Laboratory, University Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.